149 related articles for article (PubMed ID: 29089594)
1. Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positions.
Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Sato Y; Hirai Y; Hayashi Y; Ajito K
J Antibiot (Tokyo); 2018 Feb; 71(2):298-317. PubMed ID: 29089594
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 4: synthesis of novel lincomycin analogs modified at the 6- and 7-positions and their potent antibacterial activities.
Wakiyama Y; Kumura K; Umemura E; Ueda K; Watanabe T; Yamada K; Okutomi T; Ajito K
J Antibiot (Tokyo); 2017 Jul; 70(8):888-906. PubMed ID: 28559581
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of novel lincomycin derivatives. IV. Optimization of an N-6 substituent.
Kumura K; Wakiyama Y; Ueda K; Umemura E; Hirai Y; Yamada K; Ajito K
J Antibiot (Tokyo); 2017 Dec; 70(12):1112-1121. PubMed ID: 29115289
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of novel lincomycin derivatives. II. Exploring (7S)-7-(5-aryl-1,3,4-thiadiazol-2-yl-thio)-7-deoxylincomycin derivatives.
Kumura K; Wakiyama Y; Ueda K; Umemura E; Watanabe T; Kumura M; Yoshida T; Ajito K
J Antibiot (Tokyo); 2017 May; 70(5):655-663. PubMed ID: 27924113
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines.
Kumura K; Wakiyama Y; Ueda K; Umemura E; Watanabe T; Shitara E; Fushimi H; Yoshida T; Ajito K
J Antibiot (Tokyo); 2016 Jun; 69(6):440-5. PubMed ID: 26758495
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs.
Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Sato Y; Watanabe T; Hirai Y; Ajito K
J Antibiot (Tokyo); 2017 Jan; 70(1):52-64. PubMed ID: 27703159
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities.
Umemura E; Wakiyama Y; Kumura K; Ueda K; Masaki S; Watanabe T; Yamamoto M; Hirai Y; Fushimi H; Yoshida T; Ajito K
J Antibiot (Tokyo); 2013 Mar; 66(3):195-8. PubMed ID: 23232934
[No Abstract] [Full Text] [Related]
8. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
Ma C; Liu Z; Song H; Jiang R; He F; Ma S
J Antibiot (Tokyo); 2010 Jan; 63(1):3-8. PubMed ID: 19911029
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 1. Newly generated antibacterial activities against Gram-positive bacteria with erm gene by C-7 modification.
Wakiyama Y; Kumura K; Umemura E; Ueda K; Masaki S; Kumura M; Fushimi H; Ajito K
J Antibiot (Tokyo); 2016 May; 69(5):368-80. PubMed ID: 26669755
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
[TBL] [Abstract][Full Text] [Related]
12. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.
Reinert RR; van der Linden M; Al-Lahham A
Antimicrob Agents Chemother; 2005 Aug; 49(8):3520-2. PubMed ID: 16048973
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.
Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Watanabe T; Yamamoto M; Hirai Y; Ajito K
J Antibiot (Tokyo); 2016 Jun; 69(6):428-39. PubMed ID: 26669751
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of novel C12 ethyl ketolides.
Burger MT; Hiebert C; Seid M; Chu DT; Barker L; Langhorne M; Shawar R; Kidney J; Desai MC; Plattner JJ
Bioorg Med Chem; 2006 Aug; 14(16):5592-604. PubMed ID: 16697203
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.
Qi Y; Jiao B; Ma X; Cui W; Ma S
Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of novel C12 vinyl ketolides.
Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ
J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588
[TBL] [Abstract][Full Text] [Related]
20. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
Bley C; van der Linden M; Reinert RR
Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
